- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 3 - Treatment Considerations
The panelists weigh in on the appropriate standards for treating patients with NSCLC.
The panelists weigh in on the appropriate standards for treating patients with NSCLC. These options include radiation, ablation, surgery, and various therapies for the disease.
“The modern surgical techniques have made a major difference. Patients are getting out of the hospital faster, and better shape — fewer complications, fewer morbidities and the consequence of that is if they are candidate for additional treatment after that…they are far better able to tolerate that treatment,” says Dr Langer. He also suggests that surgery must be done right.
“I think there’s a variety of different methods to ablate the tumor ̶ surgery is certainly the foundation of therapy ̶ but particularly for those directing managed care coverage there are other modalities that are very effective in selective settings,” says Dr Peskin.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
